Organigram Global Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- James Yamanaka
- Full Time Employees
- 1,139
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 145 King Street West Toronto ON Canada M5H 1J8
- IPO Date
- May 21, 2019
- CIK
- 0001620737
- Website
- organigram.ca
- Similar Companies
- Business
- Organigram Global Inc. (NASDAQ/TSX: OGI) produces and sells high-quality cannabis and cannabis-derived products for medical and adult-use recreational markets in Canada and select international jurisdictions. The company offers an extensive portfolio including dried flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, lozenges, concentrates, hash, oils, and extracts; these are marketed under established brands such as SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian. Organigram Global operates state-of-the-art cultivation, processing, and manufacturing facilities in Moncton (New Brunswick), Lac-Supérieur (Quebec), Winnipeg (Manitoba), Aylmer and London (Ontario); it distributes through provincial boards, online portals, wholesale channels, and international partners in markets including Australia, Germany, Israel, and the UK. Founded in 2013 and headquartered in Toronto, Canada, with primary operations originating in Moncton, New Brunswick, the company maintains a strategic partnership with British American Tobacco, which holds a significant equity stake following investments including a C$124.6 million tranche in 2023. Recent developments include its rebranding from Organigram Holdings Inc. to Organigram Global Inc. in March 2025; the acquisition of Motif Labs in December 2024, establishing it as Canada's largest cannabis company by market share and adding extraction facilities in Aylmer and London, Ontario; and the March 2025 purchase of Collective Project Limited for up to C$24 million, enabling entry into hemp-derived THC beverages in 10 U.S. states and accelerating cannabis beverage launches in Canada.
Company News
Organigram Provides Update on Integration of Sanity Group and Unified Global Operating Model
Head-To-Head Comparison: Organigram Global (NASDAQ:OGI) versus Avita Medical (NASDAQ:RCEL)
RxSight (NASDAQ:RXST) and Organigram Global (NASDAQ:OGI) Financial Survey
Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights from Production Facilities Transcript
Organigram Global Targets Profitable Growth With Canada Focus and German Expansion
Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X
Reviewing Organigram Global (NASDAQ:OGI) & KORU Medical Systems (NASDAQ:KRMD)
Organigram Global to Host 2026 OG Investor Session
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
Organigram Global Q3 Earnings Call Highlights
Organigram Reports Record Third Quarter Fiscal 2026 Results
Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026
Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share
Organigram: Record Harvests Are The Root Of Market Share Erosion
Organigram Global Inc. (OGI:CA) Q2 2026 Earnings Call Transcript
Organigram Says Vape Weakness Pressures Margins
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
Organigram Global Q2 Earnings Call Highlights